Related Experiment Video
Updated: Jun 8, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running
Hideto Takahashi1, Koichi Kurishima, Hiroichi Ishikawa
1Life System Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Purpose:
To determine pretreatment serum CYFRA21-1 levels as indicators of poor prognosis in patients with non-small cell lung cancer (NSCLC).
Methods:
1,202 consecutive patients, diagnosed pathologically with NSCLC from January 1999 to December 2009, were entered in this study. To obtain optimal cutoff points of CYFRA21-1 for these endpoints, a running log-rank statistical method was applied.
Results:
The cutoff level for the maximum log-rank statistical value of one-year survival in patients with NSCLC was 18.0 ng/ml. These results could be applied to patients with squamous cell carcinoma. In multivariate analysis, elevated (>18.0 ng/ml) levels of CYFRA21-1 was confirmed as being an unfavourable prognostic factor.
Conclusion:
CYFRA21-1 assay has a clinical significance for identifying patients with poor prognosis among those with early and advanced NSCLC. Elevated serum CYFRA21-1 levels at the time of diagnosis may be a useful noninvasive marker for identifying the risk of early death from NSCLC.
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Censoring Survival Data
Kaplan-Meier Approach
Assumptions of Survival Analysis
Survival Tree
Building a Survival Tree
Constructing a survival tree begins...